As the capabilities of generative AI models have grown, you've probably seen how they can transform simple text prompts into hyperrealistic images and even extended video clips. More recently, ...

The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (EVGN), a leading ...

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications In both pharma and ...

Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...

Generative artificial intelligence allowed researchers to design new, synthesizable antibiotics against a dangerous and often drug-resistant human pathogen. To address this need, Stokes and his team ...

– License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique design of potent and selective macrocycles for ...

REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and ...